<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR17">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>San Miguel</surname>
    <given-names>JF</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma</article-title>
  <source>J. Clin. Oncol.</source>
  <year>2013</year>
  <volume>31</volume>
  <fpage>448</fpage>
  <lpage>455</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2012.41.6180</pub-id>
  <?supplied-pmid 23233713?>
  <pub-id pub-id-type="pmid">23233713</pub-id>
 </element-citation>
</ref>
